Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Clinical Physiology and Biochemistry|January 1, 1988
Evolution of angiotensin-converting enzyme inhibitorsM J WyvrattMedicinal Research Reviews|October 1, 1985
Recent developments in the design of angiotensin-converting enzyme inhibitorsM J Wyvratt, A A PatchettEndocrinology|June 1, 1993
Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogueK Cheng, W W Chan, B Butler, et al.Bioorganic & Medicinal Chemistry Letters|March 7, 2001
SAR studies of novel 5-substituted 2-arylindoles as nonpeptidyl GnRH receptor antagonistsL Chu, J L Lo, Y T Yang, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Investigation of the 4-O-alkylamine substituent of non-peptide quinolone GnRH receptor antagonistsR J DeVita, M T Goulet, M J Wyvratt, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2001
2-(3,5-Dimethylphenyl)tryptamine derivatives that bind to the GnRH receptorP Lin, D Marino, J L Lo, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Heterocyclic derivatives of 2-(3,5-dimethylphenyl)tryptamine as GnRH receptor antagonistsP Lin, M Parikh, J L Lo, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 1999
Acyclic structural variants of growth hormone secretagogue L-692,429P Lin, J M Pisano, W R Schoen, et al.Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moietiesL L Brockunier, M R Candelore, M A Cascieri, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptorA E Weber, R J Mathvink, L Perkins, et al.Pageof 4